Skip to content

Insmed

US · INSM #794 by market cap Listed 1970
101.74 -3.49 -3.32%
Live - 5344 symbols - heartbeat 472s ago · 2026-10-08 07:31
Pre-market 101.90 +0.16%
After-hours 103.00 +1.23%
Overnight 101.99 +0.25%
Market cap
22.22B
P/B
29.33
EPS
-6.42
Reader sentiment Are you bullish or bearish on INSM?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Announces Target Price $195
    Market Newswire · 2026/8/10
  • Rating change
    Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $212
    Market Newswire · 2026/7/23
  • Rating change
    BMO Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $192
    Market Newswire · 2026/8/18
  • Rating change
    Guggenheim Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $207
    Market Newswire · 2026/7/22
  • Goldman Sachs Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $188
    Market Newswire · 2026/9/24
  • Rating change
    Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $195
    Market Newswire · 2026/8/25
  • Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
    Market Newswire · 2026/9/23
  • Rating change
    J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $175
    Market Newswire · 2026/8/10
  • Rating change
    H.C. Wainwright Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $220
    Market Newswire · 2026/8/10
  • Rating change
    Cantor Fitzgerald Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $235
    Market Newswire · 2026/7/28
  • Rating change
    RBC Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195
    Market Newswire · 2026/8/27
  • J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $175
    Market Newswire · 2026/9/28
  • Rating change
    BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $209
    Market Newswire · 2026/8/3
  • Rating change
    A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $169 to $243
    Market Newswire · 2026/8/7
  • Rating change
    A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $170 to $237
    Market Newswire · 2026/8/8
  • Rating change
    J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $179
    Market Newswire · 2026/7/22
  • BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $214
    Market Newswire · 2026/9/22
  • Rating change
    Roth MKM Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $198
    Market Newswire · 2026/9/15
  • Rating change
    Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $218
    Market Newswire · 2026/9/13
  • Barclays Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $207
    Market Newswire · 2026/9/30

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:31:09 · For reference only, not investment advice and not tailored to your situation.